Divi's Laboratories announced a long-term supply agreement with a global pharmaceutical company, focusing on manufacturing and supplying advanced intermediates. The company anticipates significant revenue generation from this partnership.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/KBMRzNm
via IFTTT
No comments:
Post a Comment